Objectives: This study was initiated to collect retrospective information on the occurrence of plasmid-mediated quinolone resistance (PMQR) in Salmonella enterica and Escherichia coli isolates in Europe and to identify the responsible genes.
Introduction
Fluoroquinolones are important antibiotics for treatment of infections in both humans and animals. 1 Resistance to fluoroquinolones can lead to treatment failure and is therefore considered a public health risk. 2, 3 In Enterobacteriaceae, (fluoro)quinolone resistance is mainly caused by point mutations in the quinolone resistance-determining region (QRDR) of gyrase (gyrA and gyrB) and topoisomerase (parC and parE) genes. An increase in the number of mutations leads to a stepwise increase in the level of resistance to fluoroquinolones such as ciprofloxacin. However, one point mutation in gyrA results in resistance to nalidixic acid. 1 In addition, efflux pumps and decreased permeability of the outer membrane can also contribute to the level of quinolone resistance. 1 In the last decade plasmid-mediated quinolone resistance (PMQR) has been increasingly reported in Enterobacteriaceae worldwide, including several European countries. 4, 5 However, studies reporting the occurrence of PMQR genes in Enterobacteriaceae on a European level are lacking.
To date, three different transferable (fluoro)quinolone resistance mechanisms have been described: (i) five different qnr families, each with different numbers of alleles (qnrA1 -7, qnrS1-4, qnrB1-31, qnrC and qnrD) 6 (http://www.lahey.org/ qnrstudies); (ii) a modified aminoglycoside acetyl transferase gene [aac(6 ′ )-1b-cr]; 7 and (iii) a specific quinolone efflux pump (qepA) 8 and multidrug resistance pumps like oqxAB. 9 In general, PMQR-positive isolates display a distinctive phenotypic quinolone resistance pattern, which is related to a specific affinity to fluoroquinolones, resulting in reduced susceptibility to these substances, but only a minor reduction in susceptibility to nalidixic acid. 10, 11 This phenotype is only exhibited by bacterial isolates without mutations in the QRDR, but can nevertheless be of interest in retrospective studies.
In 2008, the European Union Reference Laboratory for Antimicrobial Resistance (EURL-AR; at the National Food Institute, Lyngby, Denmark) initiated a collaborative study including all the National Reference Laboratories for Antimicrobial Resistance (NRL-AR), which routinely used MIC determinations for susceptibility testing. The aim of this study was to collect retrospective information on the emergence and occurrence of PMQR in Salmonella and Escherichia coli isolates from different sources in Europe and to identify the responsible genes.
Methods
All NRLs on antimicrobial resistance in animals and food were invited by the EURL-AR to participate in a collaborative study on the occurrence of PMQR in Salmonella and E. coli. Furthermore, the National Veterinary Institute (NVI) in Norway and the Health Protection Agency Centre for Infections (HPA) in the UK were also invited to participate in this study. A questionnaire (available as Supplementary data at JAC Online) was included to collect information concerning sample identity, maintenance of strain collections, testing methods and types of databases. The NRL-AR laboratories were asked to retrospectively screen their MIC databases for E. coli and Salmonella isolates exhibiting a defined PMQR phenotype; i.e. reduced susceptibility to ciprofloxacin and nalidixic acid. Based on epidemiological cut-off values set by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) for ciprofloxacin and enrofloxacin, inclusion criteria were set for Salmonella (MICs ≥ 0.125 mg/L and ≥0.25, respectively) and E. coli (MICs ≥0.06 mg/L) combined with nalidixic acid MICs 4 -32 mg/L. The majority of the participants tested ciprofloxacin and nalidixic acid; only Poland (until 2007) and Norway (until 2006) tested for susceptibility to enrofloxacin instead.
All databases, except for the HPA, consisted of MIC values obtained with broth microdilution according to ISO-20776-1: 2006. 12 HPA used a semi-quantitative agar dilution system testing susceptibility to antibiotics at breakpoint levels. For our purpose this system provided sufficient information on the quinolone resistance phenotype as it included testing a single concentration of nalidixic acid (16 mg/L) and two different ciprofloxacin concentrations (0.125 and 1 mg/L). Isolates exhibiting growth on 0.125 mg/L ciprofloxacin but no growth on 16 mg/L nalidixic acid were considered PMQR suspected and included in the selection.
Furthermore, participants were asked to send epidemiological data (such as source and year of isolation) concerning the selected isolates to the EURL-AR in order to build a database of the PMQR-suspected isolates. Databases containing disc diffusion results were excluded from the study, since valid information on inhibition zone diameters indicative of PMQR-positive isolates was lacking. Subsequently, all participants were asked to screen their selected isolates with PCR for all known PMQR genes. PCR protocols based on published primers for each of the genes qnrA, 13 . Finally, participants were requested to sequence the amplicons to identify the detected resistance genes and their respective variants. For the identification of qnrB variants a second set of primers was used in order to analyse a larger amplicon. 20 To discriminate between qnrB5 and qnrB19 a third set of primers based on the linkage between ISEcp1C and qnrB19 was used. 21 If laboratories were not able to perform PCR and sequencing, they were invited to send their PMQR-suspected isolates either to the EURL-AR in Denmark or to the Central Veterinary Institute (CVI) in the Netherlands for further analysis.
Results
National Reference Laboratories from Belgium, the Czech Republic, Denmark, Finland, France, Germany, Ireland, Italy, Norway, Poland, Spain, the Netherlands and the UK participated in this study.
Retrospective screening of the MIC data of 661629 Salmonella isolates and 31132 E. coli isolates resulted in a selection of 1215 PMQR-suspected Salmonella and 333 PMQR-suspected E. coli isolates. Subsequently, 485 Salmonella and 133 E. coli were genetically characterized ( Table 1 ). The remaining isolates were not analysed, because they were either not stored, not viable or were retested for susceptibility and based on the new results excluded from the study. The isolates tested were obtained between 1994 and 2009 from humans, turkeys (and turkey meat), fowls (broilers, laying hens and broiler meat), pigs (and pork), cattle, sheep and reptiles, but also from food (undefined meat, food products and spices), animal feed and environmental samples.
For Salmonella, PCR testing revealed PMQR genes in 59% (288/485) of isolates tested originating from 11 different European countries (Table 1) . PMQR genes were identified in Salmonella isolates obtained from humans, turkeys, fowls, reptiles, pigs, sheep, food and the environment and in two isolates of unknown origin ( Table 2 ). The earliest PMQR-positive Salmonella isolate detected was a qnrS1-positive Salmonella Typhimurium isolate obtained in 2002 from a human in the UK.
The qnrS1 gene was predominant in the selected Salmonella isolates and was detected in 26% of the isolates (125/485). This PMQR gene variant was widespread among 25 different Salmonella serovars and was most frequently detected in Occurrence of PMQR genes in Europe human Salmonella Corvallis isolates mainly from the Netherlands and in human Salmonella Typhimurium isolates from the UK (Table 3 ). In addition, qnrS1 was frequently identified in Salmonella Saintpaul isolates obtained from turkeys in Denmark, Poland and Germany. Salmonella isolates obtained from fowls, pigs, sheep, reptiles and food were also qnrS1-positive. In two qnrS1-positive isolates from Italy the concurrent presence of the aac(6 ′ )-1b-cr gene was demonstrated. Six variants of qnrB (qnrB2, qnrB4, qnrB6, qnrB7, qnrB12 and qnrB19) were identified in 138 qnrB-positive isolates. Most qnrB-positive isolates were obtained from turkeys, but qnrB gene variants were also identified in Salmonella isolates from other sources, such as humans, reptiles and fowls (Table 2) . Within the qnrB-positive group, qnrB2 was the most frequent variant found and was particularly prevalent in Salmonella Derby and Salmonella London obtained from turkeys in Spain (Table 3) . Furthermore, qnrB19 was most often detected in Salmonella isolated from turkeys in Germany and Denmark, including Salmonella Hadar and Salmonella Newport isolates (Tables 2 and 3 ). Some of these isolates were previously reported as qnrB5 positive. 22 However, in the present study we used an extra set of primers, 21 and based on sequence analysis of the amplicons these isolates were now designated qnrB19 positive. In addition, qnrB19 was identified in a particular group of Salmonella isolated from reptiles in German zoos, 23 included in this study. In one case, aac(6 ′ )-1b-cr was detected together with qnrB6 in a Salmonella isolate from a turtle.
The qnrD genes were detected in 22 isolates from eight different serovars noted in three different countries (Table 3) . Most qnrD-positive isolates were identified in laying hens from Spain. However, qnrD genes were also detected in Salmonella isolates obtained in fowls, turkeys and food from Italy and in two human isolates from the Netherlands (Table 2) .
Finally, the qnrA1 gene was identified in two Salmonella Paratyphi B variant Java isolates from poultry products in Belgium and the Netherlands and in one Salmonella Typhimurium from turkeys in Germany (Table 3) . None of the Salmonella isolates tested was positive for qnrC or qepA genes.
A small proportion of the PMQR-positive Salmonella isolates (n¼ 10) demonstrated resistance to third-generation cephalosporins, indicative of the presence of extended-spectrum b-lactamases (ESBLs) or AmpC-type b-lactamases (data not shown).
In E. coli, 15% (20/133) of the selected isolates were PMQR-positive, originating from four different countries (Table 1) , but mostly from Poland. The isolates were obtained from food, fowls, turkeys, cattle and pigs (Table 4) . qnrS1 was detected in 19 isolates, whereas one isolate from a turkey was found to be qnrB19 positive. In this study, the earliest PMQR-positive E. coli detected were two isolates obtained in 2008 from pigs in Finland. None of the E. coli isolates tested was found to be positive for qnrC, qnrD or qepA genes. Furthermore, a single qnrS1-positive E. coli collected from a Dutch broiler exhibited resistance to third-generation cephalosporins.
In Salmonella, PMQR genes were identified in isolates with a wide range of MICs, but most PMQR genes were found in isolates with ciprofloxacin MICs of 0.25 -1 mg/L combined with nalidixic acid MICs of 8 -32 mg/L. The PMQR-positive E. coli isolates exhibited a narrow range of ciprofloxacin (0.25 -0.5 mg/L) and nalidixic acid (4 -16 mg/L) MICs.
Discussion
In general, the acquisition of PMQR genes leads to decreased susceptibility to fluoroquinolones, which affects the mutation Veldman et al. Unknown origin Occurrence of PMQR genes in Europe 
Continued prevention concentration (MPC) and may accelerate selection of fluoroquinolone-resistant mutants. 24, 25 Moreover, interactions between mutations in the QRDR and PMQR genes can result in higher MICs of ciprofloxacin. 26 Hence, data on the occurrence of PMQR genes are important for the surveillance of quinolone resistance in humans and animals. A limitation of our study was the potential exclusion of isolates in which both PMQR genes and chromosomal mutations were present. The quinolone resistance phenotype of these isolates is not indicative of the presence of PMQR genes. Isolates with mutations in the QRDR exhibit high-level resistance to nalidixic acid (MIC≥ 32 mg/L) in combination with reduced susceptibility to fluoroquinolones, independently of the presence of PMQR genes. Therefore, these phenotypes are not suitable for retrospective screening of MIC databases for PMQR. As a result, our screening method has probably underestimated the prevalence of PMQR genes in the total population, whilst coexistence of PMQR and mutations has been reported in Enterobacteriaceae from animals. 27, 28 Furthermore, the number of isolates included in this study depended on the number of isolates available in the strain collections, which varied considerably between countries (Table 1) . Also, the number of isolates selected and tested, as well as the sources, varied between countries. The Salmonella strains in the collections originated from 11 countries and were isolated from humans, animals, food and the environment. The human clinical Salmonella isolates originated from the UK and the Netherlands only. The E. coli strains in the collections originated from six countries and were solely isolated from animals and food. Therefore, in-depth epidemiological analysis of the results by country and source was not appropriate. The analysis was limited to a description of the emergence and occurrence of PMQR and its characteristics instead of prevalences by source and country. Nevertheless, the strength of our study is the selection of isolates with a defined quinolone resistance phenotype in a large strain collection, resulting in a relatively high detection rate of PMQR genes within the selection, especially in Salmonella.
We detected qnrS1 in a large number of serovars, particularly in human Salmonella Corvallis and Salmonella Typhimurium isolates. Eight qnrS1-positive Salmonella isolates from the UK originated from people with a travel history to South-East Asia (data not shown). These findings confirm earlier reports of human qnrS1-positive Salmonella isolates from Denmark and the UK associated with foreign travel or imported food from South-East Asia. 29, 30 The occurrence of qnrS1 has recently been described in four Salmonella Saintpaul isolates collected from turkey meat in Table 3 . 
Occurrence of PMQR genes in Europe Germany and Poland. 22 These four isolates were also included in our study and we identified 15 other qnrS1-positive Salmonella Saintpaul isolates collected from turkeys, fowls, humans and food. Our findings demonstrate further dissemination of this serovar to other sources. To our knowledge, we report the first qnrS1 in serovars Agona, Cerro, Derby, Goldcoast, Kingston, Mbandaka, Newport, Senftenberg, Ohio and Wandsworth and Salmonella enterica serovar 4, [5] ,12:i-, indicating horizontal transmission of this PMQR gene within S. enterica.
The majority (86%) of the qnrB-positive Salmonella isolates were of animal origin. However, this number was highly influenced by the proportion of animal isolates in the total selection and, in particular, by the number of qnrB-positive turkey isolates from Spain. Nevertheless, we identified qnrB in Salmonella of animal origin in seven different European countries.
To date, the only case of a qnrB2-positive Salmonella Bredeney isolate of animal origin was reported in a Dutch broiler chicken. 31 However, in the present study we identified qnrB2 genes in serovars Agona, Derby, Enteritidis, Hadar, London and Montevideo (Table 3) , most of them obtained from turkeys in Spain. The high number of qnrB2-positive Salmonella from Spain found in this study suggests a potential source for transmission of these genes to humans in this country. Nevertheless, reports on the occurrence of human qnrB2-positive Salmonella isolates in Spain are scarce. 32, 33 In our study, the number of qnrB2-positive human isolates was also low.
The presence of qnrB19 has been described in different Salmonella serovars of human origin, including Salmonella Typhimurium isolates from the Netherlands and Italy. 21, 34 We describe two qnrB19-positive Salmonella Paratyphi B variant Java isolates obtained from chicken products and a human patient, all collected in the Netherlands in the same period (2007 -08) suggesting transfer of this gene between animals and humans. In addition, to our knowledge, we report the first qnrB19-positive serovars: Derby, Meleagridis and Paratyphi B variant Java.
The first qnrD was described in Salmonella Kentucky and Salmonella Bovismorbificans isolates from humans in China. 16 To date, qnrD has also been reported in Morganella morganii and Proteus mirabilis from Italy 35 and in M. morganii isolates from Algeria. 36 However, to our knowledge, this is the first description of qnrD in Salmonella isolates from both humans and animals in Europe. Remarkably, the first qnrD gene in our study was detected in a human isolate collected in 2003 from the Netherlands. Moreover, we identified qnrD in Salmonella from Spain collected in 2004-08 from laying hens. These findings reveal that this newly described PMQR gene had already been present in Europe for several years, being able to spread over different European countries, before it was identified in China. Moreover, there seems to be a cluster of qnrD-positive Salmonella isolates in Italy and Spain, which should be verified by additional studies.
Although qnrA1 is the first PMQR gene described, this gene is rarely found in Salmonella. 37 -39 To our best knowledge, we describe the first qnrA1 in Salmonella isolates of animal origin in two Salmonella Paratyphi B variant Java isolates collected from poultry products and in one Salmonella Typhimurium isolate collected from a turkey. Both Salmonella Paratyphi B variant Java isolates were multidrug resistant, including resistance to cefotaxime. Moreover, the Dutch isolate was confirmed ESBL-positive, harbouring a bla CTX-M-9 in addition to a qnrA1 on an IncHI2 plasmid (data not shown). Even though qnr genes have often been associated with plasmid-encoded ESBL genes, 11, 40 in our study low numbers of such isolates were found. To date, European reports of PMQR genes in E. coli isolates of animal origin are scarce. 41 -43 In our study, 16 of the isolates originated from different healthy animals in Poland, suggesting a more frequent occurrence of PMQR-positive E. coli in this country. Almost all isolates were qnrS1-positive, but one isolate obtained from a turkey was found to be qnrB19-positive. PFGE revealed low genetic similarity of those isolates, indicating independent sources and routes of infection (data not shown). To our knowledge, we report the first qnr genes in E. coli isolates from animals in Finland (qnrS1) and Poland (qnrS1 and qnrB19). These findings indicate that PMQR genes are infrequently present in the commensal E. coli in the gut flora of foodproducing animals in Europe with reduced susceptibility to fluoroquinolones.
Within the selection the occurrence of Salmonella isolates with aac(6 ′ )-1b-cr was low and in all cases coexistence with a qnr gene was found, as described in previous studies. 27, 28 In addition, the aac(6 ′ )-1b-cr gene was not identified in any E. coli isolate. The low incidence of aac(6 ′ )-1b-cr in our study might be explained by the inclusion criteria defined for this study. Isolates with merely aac(6 ′ )-1b-cr exhibit a minor reduction in susceptibility to ciprofloxacin and therefore could have been missed in our selection. 10 Despite all the PMQR genes identified, the resistance phenotype of a relatively large proportion of the tested isolates remains unexplained: 41% of the Salmonella and 85% of the E. coli isolates tested negative for all known PMQR genes. This could be due to the presence of new undetected PMQR genes or other quinolone resistance mechanisms present or inadequate selection criteria. Since all isolates included exhibited nalidixic MICs≤ 32 mg/L, we did not look for mutations in the QRDR region. Therefore, additional analysis would be necessary to reveal other possible resistance mechanisms, such as the involvement of efflux pumps.
Summarizing, our study confirms the occurrence of PMQR-positive Salmonella isolates of human and animal origin in Europe since 2002. Moreover, the detection of PMQR genes in Salmonella obtained from animals in 10 different countries is indicative of their widespread occurrence in Europe. Within our selection, most PMQR-positive Salmonella isolates originated from Spain, the Netherlands, UK, Germany and Denmark and were predominantly obtained from humans, turkeys and fowls. Although these data are influenced by differences in the number of isolates per country and source, they suggest that poultry is the main source of PMQR determinants in Europe, with predominant serovars Derby, London, Saintpaul and Hadar. Furthermore, some of the human PMQR-positive Salmonella in this study were associated with foreign travel, particularly qnrS1-positive Salmonella Corvallis and Salmonella Typhimurium isolates. In addition, we report the first qnrD in Salmonella isolated outside of Asia. Our study also demonstrates the presence of PMQR genes in E. coli recently isolated from animals in four European countries. Despite the fact that fluoroquinolones have been used in food-producing animals since the end of the 1980s, PMQR genes occur relatively infrequently in animal isolates. This suggests that PMQR-positive isolates without additional mutations in the QRDR region are not selected Veldman et al. during treatment of animals with fluoroquinolones. Apparently the administration of fluoroquinolones in food-producing animals results in concentrations in the gastrointestinal tract that are higher than the MICs for PMQR-positive isolates. Co-selection through the use of other antibiotics may occur once PMQR genes are embedded in plasmids harbouring additional resistance genes. On the other hand, if PMQR genes do accelerate the selection of fluoroquinolone-resistant mutants during treatment of animals with fluoroquinolones, the focus of surveillance studies should also be the detection of PMQR genes in fluoroquinolone-resistant isolates. Moreover, long-term surveillance is needed for the future monitoring of trends in the occurrence of PMQR genes in Europe. Also, future studies are required focusing on plasmid analysis to understand more about the successful dissemination of PMQR genes in Enterobacteriaceae.
